Author correction to “PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism” [Acta Pharm Sin B 13 (2023) 157–173]

• DOI: 10.1016/j.apsb.2025.02.006
• Publication Date: 2025-02-12T08:11:03Z
• Authors: Mingming Sun; Leilei Li; Yujia Niu; Yingzhi Wang; Qi Yan; Fei Xie; Yaya Qiao; Jiaqi Song; Huanran Sun; Zhen Li; Sizhen Lai; Hongkai Chang; Han Zhang; Jiyan Wang; Chenxin Yang; Huifang Zhao; Junzhen Tan; Yanping Li; Shuangping Liu; Bin Lu; Min Liu; Guangyao Kong; Yujun Zhao; Chunze Zhang; Shu-Hai Lin; Cheng Luo; Shuai Zhang; Changliang Shan